AtaiBeckley ATAI
NASDAQ ATAI
$7.40 +0.06 (+0.82%)
As of: Sep 4, 2026 · 3:17 PM EDT

AtaiBeckley (ATAI) Other financing activities (2021 - 2026)

AtaiBeckley (ATAI) posted quarterly Other financing activities of $821000.0 for Q1 2026, up 106.8% year-over-year from $397000.0 in Q1 2025, and up 106.8% quarter-over-quarter from $397000.0 in Q1 2025.

Analysis

AtaiBeckley (ATAI) Other financing activities (2021 - 2026) Analysis & Trends

AtaiBeckley has reported Other financing activities for 5 years, with the latest figure at -$11.5 million in Q3 2025.

  • Quarterly Other financing activities fell 3442.64% year-over-year to -$11.5 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $535000.0 (up 604.72% YoY) and the FY2024 annual result came in at $535000.0, up 435.0% from the prior year.
  • Other financing activities for Q1 2026 stood at $821000.0, up from $397000.0 in the prior quarter.
  • The five-year high for Other financing activities was $821000.0 in Q1 2026, with the low at $397000.0 in Q1 2025.
  • A 5-year average of $209214.3 and a median of $169000.0 in 2022 frame the typical range for Other financing activities.
  • The widest YoY moves for Other financing activities: up 3320.86% in 2025, down 3442.64% in 2025.
  • Over 5 years, Other financing activities stood at -$534000.0 in 2021, then soared by 123.03% to $123000.0 in 2022, then plunged by 186.18% to -$106000.0 in 2023, then soared by 604.72% to $535000.0 in 2024, then slumped by 2258.69% to -$11.5 million in 2025.
  • According to Business Quant data, Other financing activities over the past three periods registered -$11.5 million, $11.2 million, and $397000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
10 AtaiBeckley 1.61 Bn 1.61 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.64 Mn
Mar 31, 2026 821,000.00
Sep 30, 2025 9.95 Mn
Jun 30, 2025 11.15 Mn
Jun 30, 2025 11.15 Mn
Mar 31, 2025 397,000.00
Mar 31, 2025 397,000.00
Dec 31, 2024 154,000.00
Sep 30, 2024 55,000.00
Jun 30, 2024 326,000.00
Dec 31, 2023 -1,000.00
Mar 31, 2023 206,000.00
Dec 31, 2022 123,000.00
Sep 30, 2022 1.92 Mn
Jun 30, 2022 117,000.00
Mar 31, 2022 132,000.00
Dec 31, 2021 401,000.00
Mar 31, 2021 534,000.00